MedTrace Logo

Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients

NCT02331940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-03-30

Study results available
· View outcomes & findings →

Summary

The aim of this study was to compare the tiotropium Respimat Soft Mist Inhaler and the HandiHaler in terms of their effects on sleeping oxygen saturation (SaO2) and sleep quality in patients with COPD.

Conditions

Interventions

DRUG

tiotropium

Comparison of the effect of tiotropium delivered by the Respimat Soft Mist Inhaler versus the HandiHaler on sleeping oxygen saturation and sleep quality in patients with COPD.

DEVICE

Handihaler

Inhalation via the HandiHaler once daily

DEVICE

Respimat

Inhalation via the Respimat once daily

Sponsors & Collaborators

  • University of Crete

    lead OTHER

Principal Investigators

  • Sophia E Schiza, MD, PhD · University of Crete

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-12-31
Completion
2014-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02331940 on ClinicalTrials.gov